Matthew H. Katz, MD (he/him/his)

Professor and Chair
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Matthew H. G. Katz, MD

Dr. Matthew HG Katz is currently a Professor and Chair of the department of Surgical Oncology at the University of Texas MD Anderson Cancer Center. He has extensive experience in the design and conduct of clinical trials and has led two national cooperative group studies of the effects of preoperative therapy on patients with advanced pancreatic cancer. He has published over 250 original articles that have described novel multi-modality treatment approaches for patients with this disease.

Presentation(s):

• P10: A Novel Classification of Small Bowel Adenocarcinoma Based on the Hidden Genome Classifier: A Multi-Institutional Study

  Thursday, March 21, 2024
  9:32am – 9:38am ET

• Optimizing Cancer Surgery: Updates in Technical Aspects and Documentation of Common Surgical Oncology Operations

  Thursday, March 21, 2024
  9:30am – 10:30am ET

• 45: Postoperative Complications Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)

  Thursday, March 21, 2024
  2:32pm – 2:42pm ET

• P37: CA 19-9 Normalization Following Neoadjuvant Therapy and Yield of Laparoscopy for Pancreatic Ductal Adenocarcinoma

  Friday, March 22, 2024
  2:04pm – 2:10pm ET